Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IWWM-11 2022 | The importance of improving precision therapy in B-cell lymphomas

Patrizia Mondello • 28 Oct 2022
IWWM-11 2022
B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma

Patrizia Mondello, MD, PhD, Mayo Clinic, Rochester, MN, comments on the importance of improving precision therapy in B-cell lymphomas, and how personalized treatment approaches can be used to increase response rates and reduce toxicity. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Patrizia Mondello

1:32
The importance of understanding the TME & using this to guide treatment for B-cell lymphomas
Patrizia Mondello • 16 Jun 2023
4:06
Exploring the impact of magnesium levels on the outcomes of patients with LBCL receiving axi-cel
Patrizia Mondello • 16 Jun 2023
1:07
Future considerations for the treatment of Waldenström’s macroglobulinemia
Patrizia Mondello • 28 Oct 2022
2:37
Molecular clusters and tumor-immune drivers of IgM monoclonal gammopathies
Patrizia Mondello • 28 Oct 2022

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals